Provided by Tiger Trade Technology Pte. Ltd.

BioLine Rx

2.81
+0.05001.81%
Post-market: 2.810.00000.00%16:41 EDT
Volume:3K
Turnover:8K
Market Cap:12.23M
PE:-1.53
High:3.10
Open:2.86
Low:2.80
Close:2.76
52wk High:4.56
52wk Low:2.15
Shares:4.35M
Float Shares:4.17M
Volume Ratio:0.27
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8408
EPS(LYR):-0.2856
ROE:-46.72%
ROA:-16.55%
PB:0.73
PE(LYR):-9.84

Loading ...

Company Profile

Company Name:
BioLine Rx
Exchange:
NASDAQ
Establishment Date:
2003
Employees:
22
Office Location:
Modi’in Technology Park,2 HaMa’ayan Street,Hevel Modi'in,Israel
Zip Code:
7177871
Fax:
972 8 642 9101
Introduction:
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Directors

Name
Position
Aharon Schwartz
Chairman of the Board and Independent Director
Avraham Molcho
Independent Director
B.J. Bormann
Independent Director
Gal Cohen
Independent Director
Rami Dar
Independent Director
Raphael Hofstein
Independent Director
Sandra Panem
Independent Director
Shaoyu Yan
Director

Shareholders

Name
Position
Philip Serlin
Chief Executive Officer
Mali Zeevi
Chief Financial Officer
Ella Sorani
Chief Development Officer